40,398 Shares in Tempus AI, Inc. (NASDAQ:TEM) Purchased by Partners Group Holding AG

Key Points

• Partners Group Holding AG purchased 40,398 shares of Tempus AI, valued at approximately $1,949,000, signaling strong institutional interest in the stock.
• Tempus AI's stock received multiple price target upgrades from analysts, with Guggenheim increasing its target from $65.00 to $75.00, reflecting positive market sentiment.
• Tempus AI reported a revenue increase of 89.5% compared to the same quarter last year, indicating robust growth potential despite negative earnings per share.

Partners Group Holding AG acquired a new position in Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 40,398 shares of the company's stock, valued at approximately $1,949,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Pathway Capital Management LP bought a new position in Tempus AI in the 1st quarter worth about $8,576,000. Wells Fargo & Company MN grew its stake in Tempus AI by 13.2% in the 4th quarter. Wells Fargo & Company MN now owns 2,384 shares of the company's stock worth $80,000 after acquiring an additional 278 shares in the last quarter. SeaCrest Wealth Management LLC bought a new position in Tempus AI in the 1st quarter worth about $535,000. Sumitomo Mitsui Trust Group Inc. grew its stake in Tempus AI by 31.4% in the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company's stock worth $205,284,000 after acquiring an additional 1,016,384 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA grew its stake in Tempus AI by 92.6% in the 1st quarter. Massachusetts Financial Services Co. MA now owns 578,890 shares of the company's stock worth $27,926,000 after acquiring an additional 278,311 shares in the last quarter. 24.22% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on TEM shares. Guggenheim upped their target price on shares of Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a research note on Monday, June 30th. Morgan Stanley increased their price objective on shares of Tempus AI from $65.00 to $68.00 and gave the company an "overweight" rating in a research note on Tuesday. Bank of America increased their price objective on shares of Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a research note on Wednesday, June 25th. Needham & Company LLC reiterated a "buy" rating and set a $70.00 price objective on shares of Tempus AI in a research note on Friday, August 8th. Finally, Piper Sandler reiterated a "neutral" rating on shares of Tempus AI in a research note on Friday, August 8th. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat, Tempus AI currently has a consensus rating of "Moderate Buy" and an average target price of $65.36.

Insider Buying and Selling

In other Tempus AI news, EVP Erik Phelps sold 51,317 shares of the firm's stock in a transaction on Monday, June 16th. The shares were sold at an average price of $72.56, for a total value of $3,723,561.52. Following the completion of the transaction, the executive vice president owned 97,779 shares of the company's stock, valued at approximately $7,094,844.24. This trade represents a 34.42% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Jennifer A. Doudna sold 625 shares of the firm's stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $62.52, for a total transaction of $39,075.00. Following the completion of the transaction, the director directly owned 26,554 shares of the company's stock, valued at approximately $1,660,156.08. This represents a 2.30% decrease in their position. The disclosure for this sale can be found here. Insiders sold 802,772 shares of company stock valued at $54,080,775 over the last quarter. Insiders own 27.60% of the company's stock.

Tempus AI Price Performance

Shares of TEM opened at $73.78 on Friday. The company has a market cap of $12.77 billion, a price-to-earnings ratio of -62.00 and a beta of 4.98. Tempus AI, Inc. has a twelve month low of $31.36 and a twelve month high of $91.45. The company has a quick ratio of 1.56, a current ratio of 1.54 and a debt-to-equity ratio of 2.58. The company has a 50 day moving average of $63.13 and a two-hundred day moving average of $58.57.

Tempus AI (NASDAQ:TEM - Get Free Report) last announced its earnings results on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, beating the consensus estimate of ($0.23) by $0.01. The company had revenue of $314.64 million during the quarter, compared to the consensus estimate of $296.84 million. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. Tempus AI's revenue was up 89.5% compared to the same quarter last year. During the same period last year, the firm earned ($6.86) earnings per share. As a group, analysts predict that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.